Ulcerative Colitis - Page 11 
The MD Magazine Ulcerative Colitis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Psychological Therapies Help IBS Patients Long-Term
Adults afflicted with irritable bowel syndrome (IBS) and other gastrointestinal symptoms can benefit both short- and long-term from psychological therapies.
As a nonprofit organization OpenBiome is becoming one of the leaders in fecal microbiota transplantation technology and also working to boost other areas of public health as well.
Anti-inflammatory treatment for children’s Crohn’s disease alters the components of their gut microbiome but does not fully restore the microbial balance.
Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.
There is growing clinical evidence that inflammatory bowel disease (IBD) can have significant pulmonary manifestations and may be more effectively treated with a multi-specialty approach.
Researchers have found that low and high doses of the experimental immunotherapy drug ozanimod achieve better results than placebo for patients with ulcerative colitis.
People suffering from irritable bowel syndrome (IBS) also often have lower levels of vitamin D.
The US Food and Drug Administration recently approved the Fenix Continence Restoration System for the treatment of fecal incontinence for patients who have tried and failed other medical and surgical options.
Collaboration between gastroenterologists and pathologists is essential in arriving at an accurate diagnosis for precursor lesions in inflammatory bowel disease (IBD) patients.

Most Popular


$vacMongoViewPlus$ $vAR$